期刊文献+

急性白血病患者中ICAM-1和VCAM-1的表达及意义 被引量:7

Expression and significance of intercelluar adhesion molecule-1 and vascular cell adhesion molecule-1 in patients with acute leukemia
下载PDF
导出
摘要 目的探讨细胞间黏附分子1(ICAM-1)和血管细胞间黏附分子1(VCAM-1)在急性白血病(AL)中的表达及临床意义。方法39例初诊AL患者,其中27例经治疗后达完全缓解(CR)。采用逆转录-PCR法检测AL骨髓单个核细胞ICAM-1和VCAM-1的 mRNA表达水平。对照组12例均为骨髓像正常的门诊患者。结果ICAM-1和VCAM-1水平在初诊AL者明显高于CR组及对照组(P<0.01),且CR组和对照组之间无显著差异(P>0.05);高白细胞(WBC>100×109/L)组和死亡组的ICAM-1和VCAM-1水平明显增高(P<0.05)。髓外浸润组仅ICAM-1高于非髓外浸润组(P<0.01);非淋巴细胞AL(ANLL)具有良好核型者ICAM-1水平低于其他患者(P<0.05)。结论AL表达ICAM-1和VCAM-1明显增高,其检测对疗效及预后判断有重要意义。 Objective To investigate the expression and its significance of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in acute leukemia (AL). Methods The expressions of ICAM-1 and VCAM-1 were detected by reverse transcriptase-PCR analysis in bone marrow mononuclear cells of 39 untreated AL. Twenty-seven of 39 patients achieved complete remission (CR) after chemotherapy. Twelve out-patients with normal bone marrow were taken as the controls. Results The expressions of ICAM-1 and VCAM-1 in untreated group were much higher than those in the control and CR group (P〈0. 01), which were not significantly different between CR group and control group (P〈0. 05). Elevated levels of ICAM-1 and VCAM-1 were seen in hyperleukocyte group (WBC〉100 10^9/L) and death group(P〈0. 05). The untreated patients with extramedullary invasion showed higher expression of ICAM-1, but not VCAM-1, than those without extramedullary invasion (P〈0.01 ). The untreated ANLL patients with good prognostic karyotype showed lower expression of ICAM-1 than other patients (P〈0. 05). Conclusion The expressions of ICAM-1 and VCAM-1 were abnormal in AL, which may be taken as a useful marker for evaluating the therapeutic efficacy and prognosis.
出处 《江苏医药》 CAS CSCD 北大核心 2007年第8期765-767,共3页 Jiangsu Medical Journal
基金 国家自然科学基金资助(30500603)
关键词 细胞间黏附分子1 血管细胞间黏附分子1 急性白血病 Intercelluar adhesion molecule-1 Vascular cell adhesion molecule-1 Acute leukemia
  • 相关文献

参考文献7

  • 1林如峰,陆化,沈文怡,刘澎,王永韧,汪承亚,李建勇.蛋白酶体抑制剂PS-341对多发性骨髓瘤间充质干细胞IL-1β表达的影响[J].江苏医药,2006,32(4):337-339. 被引量:3
  • 2曹华祥,周士福,许示心,费伯健,丁永斌.VCAM-1表达与乳腺癌血管生成及临床病理的关系[J].江苏医药,2003,29(7):491-493. 被引量:3
  • 3Graf M,Reif S,Hecht K,et al.High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia(AML)[J].Ann Hematol,2005,84(5):287-297.
  • 4Whiteway A,Corbett T,Anderson R,et al.Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission[J].Br J Haematol,2003,120(3):442-451.
  • 5Liu K,Caldwell SA,Abrams SI.Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency[J].Cancer Res,2005,65(3):1045-1054.
  • 6Bogetto L,Gabriele E,Cariati R,et al.Bidirectional induction of the cognate receptor-ligand alpha 4/VCAM-1 pair defines a novel mechanism of tumor intravasation[J].Blood,2000,95(7):2397-2406.
  • 7Zhang W,Zhang X,Fan X,et al.Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia[J].Clin Lab Haematol,2006,28(3):177-182.

二级参考文献13

  • 1沈文怡,陆化.骨髓微环境与多发性骨髓瘤[J].白血病.淋巴瘤,2004,13(3):183-185. 被引量:7
  • 2沈文怡,陆化,唐宇宏,费小明,张晓艳,刘澎,汪承亚.多发性骨髓瘤骨髓间充质干细胞多种细胞因子的异常表达[J].南京医科大学学报(自然科学版),2005,25(4):239-242. 被引量:10
  • 3林如峰,陆化,刘澎,沈文怡,张建富,吴雨洁,费小明,李建勇.蛋白酶体抑制剂PS-341对多发性骨髓瘤骨髓间充质干细胞多种细胞因子表达的影响[J].中国实验血液学杂志,2006,14(1):61-64. 被引量:7
  • 4Vito ML.A review of the cytokine network in multiple myeloma.Cancer,2003,97:2440-2452.
  • 5Wallace SR,Oken MM,Lunetta KL,et al.Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.Cancer,2001,91:1219-1230.
  • 6Rajkmar SV,Richardson PG,Hideshima T et al.Proteasome inhibition as a novel therapeutic target in human cancer.J of Clin Oncol,2005,23:630-639.
  • 7Richardson PG,Mitsiades CS,Hideshima T.Novel biological therapies for the treatment of multiple myeloma.Best Pract Res Clin Haematol,2005,18:619-634.
  • 8Voorhees PM,Claire Dees E,O'Neil B,et al.Proteasome as a target for cancer therapy.Clin Cancer Research,2003,9:6316-6325.
  • 9Aitun M,Galardy PG,Shringarpure R,et al.Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells.Cancer Res,2005,65:7896-7901.
  • 10Blade J,Cibeira MT,Rosinol L.Bortezomib:a valuable new antineoplastic strategy in multiple myeloma.Acta Oncol,2005,44:440-448.

共引文献4

同被引文献61

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部